Author

Yanli Li

Primary ORCID profile (0000-0001-6190-9849 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Yanli LiiD2 papers · Australian National University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Aaron S. Mansfiled· 1 shared Chunhua Chen· 1 shared Eugene D. Kwon· 1 shared Haidong DongiD· 1 shared Kun Ling· 1 shared Liewei Wang· 1 shared Roxana S. Dronca· 1 shared Sean S. ParkiD· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aaron S. Mansfiled

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

B7-H1(PD-L1) confers chemoresistance through ERK and p38 MAPK pathway in tumor cells

Xiaosheng Wu, Yanli Li, Xin Liu, Siyu Cao, Susan M. Harrington, Chunhua Chen, Aaron S. Mansfiled, Roxana S. Dronca, Sean S. Park, Yiyi Yan, Eugene D. Kwon, Liewei Wang, Kun Ling, Haidong Dong

This study shows B7-H1(PD-L1) promotes chemoresistance in tumor cells via ERK pathway activation and reduces it via p38 MAPK pathway activation when B7-H1 is deficient.

bioRxiv · Apr 25, 2018 · PreprintCancer Biology